TGA Registration Update

AnteoTech Ltd (ASX: ADO) (“AnteoTech” or “the Company”) provides an update on its Therapeutic Goods Administration (TGA) submission for the registration of its EuGeni Reader and SARS CoV-2 Ag Rapid Diagnostic Test (RDT). In response toTGA’s review of the submission, AnteoTech intends to collect further clinical data based on samples collected directly from patients and immediately analysed on the